You are here: Home / Protocols

Protocols

EDRN investigators protocols. The following is a list of the EDRN protocols that have been captured and curated. Additional information will be added as it is available. Contact information is provided as part of the detail for each protocol.

Contents

Title Abstract Investigator
Identification of biomarkers for lung cancer in never smokers The overall goal of this project is to identify, verify and apply biomarkers for the early diagnosis or risk assessment of lung cancer in never smokers. The ... Gazdar, Adi
Identification of protein and genetic biomarkers of prostate cancer and risk factors for progression of disease Purpose/Objectives To collect biological samples from subjects with prostate cancer to improve the accuracy of screening tests, identify markers that will ... Leach, Robin J
Improving Prostate Cancer Outcome Prediction Through Noninvasive exRNA Assessment We propose to compare men with clear progression to those with clear non-progression. We will define clear progression by an increase in overall risk as ... Carroll, Peter R.
Inflammation as a Potential Marker of Risk ad Progression for Prostate Cancer Leach, Robin J
Integrated Development of Novel Molecular Markers Sidransky, David
Intergrated Systems Biology Approach for Ovarian Cancer Biomarker Discovery The overall objective is to validate serum protein markers for early diagnosis of ovarian cancer with the ultimate goal being to develop a multiparametric ... Diamandis, Eleftherios P.
Light Scattering Spectroscopy for the Detection of Colorectal Neoplasia Lynch, Henry
Liver Cancer Reference Set Application (Rapid): Chilkoti (2019) Chilkoti, Ashutosh
Liver Full Reference Set Application :Timothy Block - Drexel Univ (2010) The goal of this application is to determine if the levels of serum GP73 and fucosylated kininogen/acute phase proteins can be used to detect hepatocellular ... Block, Timothy
Liver Full Reference Set Application: David Lubman - Univ of Michigan (2011) In this work we will perform the next step in the biomarker development and validation. This step will be the Phase 2 validation of glycoproteins that have ... Lubman, David
Liver Full Reference Set Application: Hiro Yamada - Wako (2011) Wako has received new 510(k) clearance for Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3) and Des-gamma-carboxy prothrombin (DCP) ... Yamada, Hiro
Liver Rapid Reference Set Application ( #2): Lubman - Univ of Michigan (2010) We are requesting the reference set, which includes 50 HCC cases and 50 cirrhotic controls. In our preliminary study, AFP had a AUROC of 0.66 while the AUROC ... Lubman, David
Liver Rapid Reference Set Application (#1): David Lubman - Univ of Michigan (2009) We are requesting the reference set, which includes 50 HCC cases and 50 cirrhotic controls. In our preliminary study, AFP had a AUROC of 0.66 while the AUROC ... Lubman, David
Liver Rapid Reference Set Application (#1): Laura Beretta-FHCRC (2011) Test 2 candidate biomarkers for early detection of HCC. Marker S and Marker L. Beretta, Laura
Liver Rapid Reference Set Application (#2): Laura Beretta-FHCRC (2011) Test 2 candidate biomarkers for early detection of HCC. Marker S and Marker L. Beretta, Laura
Liver Rapid Reference Set Application: Gary Norman-INOVA (2012) We have developed a new and novel assay for the detection of Golgi protein 73 (GP73), also known as Golgi membrane protein 1 (Golm1) or Golgi phosphoprotein 2 ... Norman, Gary L.
Liver Rapid Reference Set Application: Gianluigi Giannelli - Univ of Bari (2008) To evaluate biomarker performance in an out-side cohort of LC and HCC patients Giannelli, Gianluigi
Liver Rapid Reference Set Application: Hemken - Abbott (2015) The aim for this testing is to find a small panel of biomarkers (n=2-5) that can be tested on the Abbott ARCHITECT automated immunoassay platform for the early ... Hemken, Philip M
Liver Rapid Reference Set Application: Hiro Yamada - Wako (2011) Measure clinical effectiveness of AFP-L3 and DCP for early detection of HCC in patient samples collected prospectively during surveillance. However since such ... Yamada, Hiro
Liver Rapid Reference Set Application: Kevin Qu-Quest (2011) We propose to evaluate the performance of a novel serum biomarker panel for early detection of hepatocellular carcinoma (HCC). This panel is based on markers ... Qu, Kevin
Liver Rapid Reference Set Application: Timothy Block - Drexel Univ (2008) The goal of this application is to determine if the levels of serum GP73 and fucosylated kininogen/acute phase proteins can be used to detect hepatocellular ... Block, Timothy
Liver Reference Set-Rapid-Application: Nilsson Glycobond (2018) Nilsson, Anki
Lung Reference Set A Application: Edward Hirschowitz - University of Kentucky (2009) We are continuing validation with two advanced objectives: 1) To evaluate assay performance for established lung cancer diagnosed in a clinical population 2) ... Hirschowitz, Edward
Lung Reference Set A Application: Dawn Coverley- University of York (2011) A variant of the nuclear matrix factor Ciz1 is prevalent in lung cancer cell lines and tumours, but not in adjacent lung tissue, giving rise to a protein that ... Coverley, Dawn
Lung Reference Set A Application: LaszloTakacs - Biosystems (2010) We would like to access the NCI lung cancer Combined Pre-Validation Reference Set A in order to further validate a lung cancer diagnostic test candidate. Our ... Takacs, Laszlo
Lung Reference Set A Application: Lee Goodglick/ Eleftherios Diamandis- UCLA/MSH (2009) To study of the utility of KLK8, 11, 12, 13, and 14 profiles in diagnosing lung cancer. Chia, David
Lung Reference Set A Application: Pierre Massion-Vanderbilt (2017) Massion, Pierre
Lung Reference Set C Application: Rachel Ostroff - SomaLogics (2010) Analysis of the EDRN lung biomarker samples will enable the next step in development of a clinical diagnostic assay for the differential diagnosis of lung ... Ostroff, Rachel
MALDI Dilution Data: Randolph Feng, Ziding
MMR protein expression in HNPCC Lynch, Henry
Announcement 09/27/2019
Thank you to everyone who made the 11th EDRN Scientific Workshop a success. The next EDRN Steering Committee Meeting is from Tuesday-Thursday, March 31-April 2, 2020 in Tempe, AZ.
Announcement



 
This icon signifies that something is happening and we kindly ask you to please wait